CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 172 filers reported holding CARA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -75.0% | 10,100 | -33.6% | 0.00% | -100.0% |
| Q4 2021 | $24,000 | -29.4% | 15,200 | -49.7% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | -70.9% | 30,200 | -35.1% | 0.00% | -66.7% |
| Q2 2021 | $117,000 | -64.8% | 46,500 | +204.3% | 0.00% | -83.3% |
| Q1 2021 | $332,000 | +3588.9% | 15,282 | +27.4% | 0.02% | – |
| Q4 2020 | $9,000 | +125.0% | 12,000 | -10.4% | 0.00% | – |
| Q3 2020 | $4,000 | -75.0% | 13,400 | -35.0% | 0.00% | -100.0% |
| Q1 2020 | $16,000 | -11.1% | 20,600 | +73.1% | 0.00% | 0.0% |
| Q4 2019 | $18,000 | -93.0% | 11,900 | +10.7% | 0.00% | -93.8% |
| Q3 2018 | $258,000 | +8500.0% | 10,753 | +7.5% | 0.02% | – |
| Q2 2018 | $3,000 | -72.7% | 10,000 | -14.5% | 0.00% | -100.0% |
| Q2 2017 | $11,000 | -70.3% | 11,700 | -20.9% | 0.00% | -50.0% |
| Q1 2017 | $37,000 | – | 14,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |